Health

Black Tea can prevent SARS-CoV-2 from replicating

The year 2020 has left unforgettable memories in us and the reason is pretty obvious. This was the first time when the current generation had to face such a disastrous event, Covid-19 spread by the virus Sars-CoV-2 covering the entire planet has made us realize how important it is to focus on our health and wellness and how important it is to pay attention to what we eat, what we drink. There have been thousands of research papers published on this disease and many experts have come together to prevent it from spreading, I must say that we have been successful to a huge extent.

Black Tea can prevent SARS-CoV-2 from replicating
Black Tea can prevent SARS-CoV-2 from replicating

While we all might have heard about the importance of black tea but do you know that this also helps in preventing the virus from replicating? Yes, you heard right, recent ground-breaking research from the collaboration of from Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) and Institute of Himalayan Bioresource Technology (IHBT), Himachal Pradesh showed that a compound named Theaflavin 3-gallate, a naturally occurring bioactive molecule which is derived from Theaflavin and found in abundance in black tea, has the capability to limit replication of SARS-CoV-2 coronavirus. The organization showed that the CCMB-IHBT study that Theaflavin 3-gallate inhibits the main protease (Mpro) of SARS-CoV-2 and reduces its count in Vitro was published in the prestigious Nature journal on July 30. This chemical in black tea is found by fermentation of green tea and is used in various medicines. Though it is not proven scientifically that this tea can prevent other diseases but people still tend to consume it against diseases like diabetes, heart disease, cholesterol, hypertension, obesity, etc.

The study explored the possibility of preventing the virus from multiplication using a particular compound. In the CCMB research lab of senior scientist, B Kiran Kumar, noted, that the main protease (Mpro) of SARS-CoV-2 has been explored as an attractive drug target because of its central role in viral replication. Their findings suggest that Theaflavin 3-gallate effectively targets the Mpro thus limiting the replication of the SARS-CoV-2 virus in vitro.

The researchers in a laboratory study showed that treatment of SARS-CoV-2 with 200 μM of theaflavin 3-gallate in-vitro using Vero cells and quantifying viral transcripts leads to a reduction of viral count by 75%.

In the end, the researchers further said, that their findings suggest that theaflavin 3-gallate effectively targets the Mpro thus limiting the replication of the SARS-CoV-2 virus in vitro.

Related Posts

1 of 217